Author (year) | Azithromycin group | Amox-clav group | P-Value |
---|---|---|---|
Daniel (1993) | 7.77% | 3.7% | N/A |
Schaad (1993) | 11.7% | 22.4% | < 0.002 |
Principi (1995) | 4.5% | 8.3% | 0.0146 |
Arguedas et al. (1996) | 17.% | 66.7% | N/A |
Gerson (1996) | 3.5% | 31% | < 0.001 |
Mohini (1996) | 7.2% | 17.11% | < 0.001 |
Samuel (1996) | 8.8% | 32.64% | < 0.0001 |
Dagan (2000) | 21.7% | 27.12% | 0.327 |
Arrieta et al. (2003) | 31.8% | 42.07% | 0.095 |
Block et al. (2003) | 16.8% | 22.54% | NS |
Dune et al. (2003) | 11.2% | 20% | 0.014 |
Hoberman et al. (2005) | 35.3% | 37.9% | NS |
Guven et al. (2006) | 4.4% | 4.76% | NS |
Arguedas et al. (2011) | 45.6% | 64.16% | N/A |